Back to search

Article

Treatment of Persistent Post-Traumatic Headache with the Anti-CGRP Receptor Antibody Erenumab: A Case Report

2021-11-01

Abstract excerpt

<title>Abstract</title> <p> <italic>Introduction:</italic> Calcitonin gene-related peptide (CGRP) has only recently emerged as a potential target in posttraumatic headache. To our knowledge this is the first description of a patient with persistent posttraumatic headache following severe traumatic head injury who has been treated with the CGRP-receptor-monoclonal antibody erenumab. <italic>Case presentation:</...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
798c254d-5cf0-5e96-a629-d159321a5697
DOI
10.21203/rs.3.rs-267455/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treatment of Persistent Post-Traumatic Headache with the Anti-CGRP Receptor Antibody Erenumab: A Case ReportDOI 10.21203/rs.3.rs-267455/v2
Efficacy, Tolerability, and Safety of Erenumab for the Preventive Treatment of Persistent Post-Traumatic Headache attributed to Mild Traumatic Brain Injury: An Open-Label Study.Semantic proximity
Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity
Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity
Hypersensitivity to Calcitonin Gene–Related Peptide in Post‐Traumatic HeadacheSemantic proximity
Cluster headache: new targets and options for treatmentSemantic proximity
Phenotype-guided Management of Post-traumatic Headache: An Update on Pathophysiology and Treatment.Semantic proximity
Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertensionSemantic proximity
Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity
Persistent post-traumatic headache attributed to mild traumatic brain injury: Deep phenotyping and treatment patterns.Semantic proximity
Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity
Post-traumatic headache two to four months after mild traumatic brain injury: A description of phenotypes and treatment patterns.Semantic proximity
Effectiveness and Tolerability of Anti-Calcitonin Gene-related Peptide Therapy for Migraines and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USASemantic proximity
Select a neighboring publication to make it the new centre.